The role of myeloid derived suppressor cells in musculoskeletal disorders.
bone metabolism
immune cells
inflammation
myeloid derived suppressor cell (MDSC)
osteoblast
osteoclast
osteoimmunology
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
07
01
2023
accepted:
21
02
2023
entrez:
20
3
2023
pubmed:
21
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
The immune system is closely linked to bone homeostasis and plays a pivotal role in several pathological and inflammatory conditions. Through various pathways it modulates various bone cells and subsequently sustains the physiological bone metabolism. Myeloid-derived suppressor cells (MDSCs) are a group of heterogeneous immature myeloid-derived cells that can exert an immunosuppressive function through a direct cell-to-cell contact, secretion of anti-inflammatory cytokines or specific exosomes. These cells mediate the innate immune response to chronic stress on the skeletal system. In chronic inflammation, MDSCs act as an inner offset to rebalance overactivation of the immune system. Moreover, they have been found to be involved in processes responsible for bone remodeling in different musculoskeletal disorders, autoimmune diseases, infection, and cancer. These cells can not only cause bone erosion by differentiating into osteoclasts, but also alleviate the immune reaction, subsequently leading to long-lastingly impacted bone remodeling. In this review, we discuss the impact of MDSCs on the bone metabolism under several pathological conditions, the involved modulatory pathways as well as potential therapeutic targets in MDSCs to improve bone health.
Identifiants
pubmed: 36936946
doi: 10.3389/fimmu.2023.1139683
pmc: PMC10020351
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1139683Informations de copyright
Copyright © 2023 Ren, Bäcker, Müller and Kienzle.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Nanosci Nanotechnol. 2016 Jan;16(1):219-28
pubmed: 27398448
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Nat Microbiol. 2016 Apr 18;1:16051
pubmed: 27572649
J Leukoc Biol. 2013 Apr;93(4):633-7
pubmed: 23341539
Clin Immunol. 2015 Apr;157(2):175-86
pubmed: 25680967
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7
pubmed: 22123971
J Bone Miner Res. 2009 Jul;24(7):1150-61
pubmed: 19335218
J Med Chem. 2017 Mar 23;60(6):2326-2343
pubmed: 28121436
Cancer Res. 2020 Feb 15;80(4):784-797
pubmed: 31848193
Clin Cancer Res. 2016 Aug 1;22(15):3924-36
pubmed: 26957562
Sci Immunol. 2020 Feb 21;5(44):
pubmed: 32086381
Cancer Res. 2006 Jan 15;66(2):1123-31
pubmed: 16424049
Cells. 2019 Dec 15;8(12):
pubmed: 31847487
Front Immunol. 2019 Aug 16;10:1954
pubmed: 31475013
Cytokine Growth Factor Rev. 2004 Feb;15(1):49-60
pubmed: 14746813
Mol Nutr Food Res. 2013 Jun;57(6):1046-54
pubmed: 23417831
Front Immunol. 2020 Oct 19;11:561294
pubmed: 33193330
Bone. 2020 Sep;138:115492
pubmed: 32585321
Genom Data. 2014 Oct 31;2:389-92
pubmed: 26484135
Infect Immun. 2017 Jul 19;85(8):
pubmed: 28533469
J Bone Oncol. 2018 Nov 07;16:100206
pubmed: 31334002
J Mol Med (Berl). 2016 Aug;94(8):911-20
pubmed: 26936474
J Exp Med. 2000 Jan 17;191(2):275-86
pubmed: 10637272
J Clin Invest. 2012 Dec;122(12):4592-605
pubmed: 23114597
Immunol Cell Biol. 2017 Jan;95(1):42-55
pubmed: 27430527
J Bone Miner Res. 2008 Feb;23(2):278-86
pubmed: 17907924
Endocr Rev. 2010 Jun;31(3):266-300
pubmed: 20051526
Immunity. 2010 Jun 25;32(6):790-802
pubmed: 20605485
Bonekey Rep. 2014 Aug 06;3:561
pubmed: 25120911
J Immunol. 2014 Apr 15;192(8):3778-92
pubmed: 24646737
Cancer Res. 2020 Mar 1;80(5):1036-1048
pubmed: 31911552
Curr Opin Immunol. 2018 Apr;51:76-82
pubmed: 29547768
Front Immunol. 2021 Apr 27;12:606024
pubmed: 33986739
Cancer Res. 2013 Jan 15;73(2):672-82
pubmed: 23243021
Immunity. 2016 Jun 21;44(6):1434-43
pubmed: 27317262
Bone. 2004 Nov;35(5):1059-68
pubmed: 15542030
Cells. 2020 Sep 10;9(9):
pubmed: 32927921
Clin Cancer Res. 2018 Oct 1;24(19):4834-4844
pubmed: 29914893
Int J Mol Sci. 2020 Jul 21;21(14):
pubmed: 32708317
Rheumatology (Oxford). 2021 May 14;60(5):2409-2420
pubmed: 33246326
Theranostics. 2020 Jan 1;10(1):17-35
pubmed: 31903103
J Immunol. 2019 Dec 15;203(12):3447-3460
pubmed: 31704881
J Clin Invest. 2020 Jul 1;130(7):3603-3620
pubmed: 32484460
Arthritis Res Ther. 2021 Nov 16;23(1):287
pubmed: 34784965
J Exp Med. 2012 Mar 12;209(3):537-49
pubmed: 22351931
Blood. 2016 Sep 22;128(12):1590-603
pubmed: 27418644
J Cell Biochem. 2018 Nov;119(10):8204-8219
pubmed: 29923217
Infect Immun. 2018 Nov 20;86(12):
pubmed: 30249747
Clin Cancer Res. 2017 Jan 15;23(2):587-599
pubmed: 27401249
Int J Mol Sci. 2021 Mar 11;22(6):
pubmed: 33799644
Sci Transl Med. 2016 Mar 23;8(331):331ra40
pubmed: 27009269
J Immunother Cancer. 2018 Oct 11;6(1):104
pubmed: 30305172
J Clin Med. 2020 Jul 06;9(7):
pubmed: 32640676
J Orthop Trauma. 2014 Mar;28(3):e49-55
pubmed: 23912859
J Immunol. 2021 Feb 15;206(4):751-765
pubmed: 33419769
J Bone Miner Res. 2016 Oct;31(10):1899-1908
pubmed: 27161765
Aging Cell. 2017 Jun;16(3):480-487
pubmed: 28229533
Mech Ageing Dev. 2005 Apr;126(4):505-11
pubmed: 15722109
Oxid Med Cell Longev. 2016;2016:3565127
pubmed: 27247702
Ann Rheum Dis. 2016 Jan;75(1):278-85
pubmed: 25371442
Cancer Immunol Immunother. 2018 Aug;67(8):1271-1284
pubmed: 29923026
J Orthop Res. 2021 Feb;39(2):415-425
pubmed: 33325074
JB JS Open Access. 2020 Aug 12;5(3):
pubmed: 32984749
Antimicrob Agents Chemother. 2003 Jan;47(1):317-23
pubmed: 12499208
Nat Rev Nephrol. 2018 Feb;14(2):121-137
pubmed: 29225343
Eur J Immunol. 2010 Jan;40(1):22-35
pubmed: 19941314
Blood. 2011 Aug 25;118(8):2254-65
pubmed: 21734236
Nature. 2013 Mar 14;495(7440):227-30
pubmed: 23434756
J Leukoc Biol. 2016 Dec;100(6):1239-1254
pubmed: 27671246
Clin Cancer Res. 2017 Sep 1;23(17):5034-5043
pubmed: 28536308
Bone. 2010 Sep;47(3):472-9
pubmed: 20601290
Front Med. 2021 Apr;15(2):232-251
pubmed: 32876877
Oncotarget. 2017 Dec 7;8(70):114554-114567
pubmed: 29383101
Cell Metab. 2013 Nov 5;18(5):749-58
pubmed: 24140021
J Proteome Res. 2018 Jan 5;17(1):486-498
pubmed: 29139296
Cancer Immunol Res. 2020 Jun;8(6):819-828
pubmed: 32238380
Immunity. 2021 May 11;54(5):875-884
pubmed: 33979585
Gerontology. 2016;62(2):128-37
pubmed: 26088283
Ann N Y Acad Sci. 2010 Mar;1192:84-94
pubmed: 20392222
Blood. 2004 May 1;103(9):3258-64
pubmed: 14726388
Oncoimmunology. 2012 Dec 1;1(9):1484-1494
pubmed: 23264895
Mol Immunol. 2021 Sep;137:187-200
pubmed: 34274794
Mol Cell Biochem. 2007 Jul;301(1-2):209-17
pubmed: 17286202
Front Immunol. 2018 Aug 10;9:1822
pubmed: 30147691
Adv Healthc Mater. 2019 Feb;8(4):e1801106
pubmed: 30328293
J Dent Res. 2022 Mar;101(3):348-356
pubmed: 34636272
Int J Med Sci. 2021 Feb 19;18(8):1824-1830
pubmed: 33746599
J Clin Invest. 2017 Jun 1;127(6):2030-2039
pubmed: 28569732
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):
pubmed: 33597299
J Clin Invest. 2012 Jul;122(7):2601-12
pubmed: 22706308
J Leukoc Biol. 1989 Mar;45(3):262-73
pubmed: 2522492
J Bone Oncol. 2017 Nov 01;9:59-64
pubmed: 29226090
Hepatology. 2018 Nov;68(5):1922-1936
pubmed: 29774578
Cancers (Basel). 2021 Jan 08;13(2):
pubmed: 33430105
Acta Biomater. 2020 Feb;103:318-332
pubmed: 31857257
Nature. 2017 Oct 25;550(7677):S193
pubmed: 29069072
Nat Rev Rheumatol. 2015 Jan;11(1):45-54
pubmed: 25266456
Cell. 2020 Mar 5;180(5):968-983.e24
pubmed: 32109415
Blood. 2010 Jul 15;116(2):210-7
pubmed: 20304810
J Orthop Res. 2018 Jun;36(6):1605-1613
pubmed: 29139571
Vitam Horm. 2006;74:357-70
pubmed: 17027523
Annu Rev Pathol. 2011;6:121-45
pubmed: 20936937
J Proteome Res. 2017 Jan 6;16(1):238-246
pubmed: 27728760
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33373331
Cancer Cell. 2004 Oct;6(4):409-21
pubmed: 15488763
Int J Nanomedicine. 2019 Jan 11;14:469-481
pubmed: 30666108
Bone. 2023 Mar;168:116675
pubmed: 36638904
Cell Death Dis. 2019 Dec 9;10(12):941
pubmed: 31819035
Immunity. 2020 May 19;52(5):856-871.e8
pubmed: 32289253
Int J Mol Sci. 2020 Oct 18;21(20):
pubmed: 33081041
Eur Cell Mater. 2021 Jun 21;41:774-792
pubmed: 34151416
Immunol Invest. 2018 Nov;47(8):844-854
pubmed: 31282803
Immunity. 2019 Aug 20;51(2):351-366.e6
pubmed: 31303400
Trends Endocrinol Metab. 2013 Jun;24(6):290-300
pubmed: 23499155
J Autoimmun. 2015 Dec;65:82-9
pubmed: 26318644
Cell Rep. 2020 Dec 29;33(13):108571
pubmed: 33378668
J Neurochem. 2013 Apr;125(1):74-88
pubmed: 23278273
J Leukoc Biol. 2015 Dec;98(6):1003-13
pubmed: 26232453
Physiol Rev. 2017 Oct 1;97(4):1295-1349
pubmed: 28814613
J Bone Miner Res. 2018 Oct;33(10):1748-1759
pubmed: 29750826
Int J Biol Sci. 2019 Jan 1;15(1):58-68
pubmed: 30662347
Histochem Cell Biol. 2018 Apr;149(4):325-341
pubmed: 29392395
Clin Sci (Lond). 2020 Aug 28;134(16):2209-2222
pubmed: 32808653
Acta Biomater. 2020 May;108:223-236
pubmed: 32165192
Inflammation. 2014 Jun;37(3):670-7
pubmed: 24264477
Biomed Res Int. 2020 Apr 23;2020:2603873
pubmed: 32382539
FASEB J. 2018 Jul;32(7):3730-3741
pubmed: 29475373
Bone. 2018 Jan;106:78-89
pubmed: 26529389
Biochem Biophys Res Commun. 2022 Dec 25;636(Pt 2):87-96
pubmed: 36368159
Front Immunol. 2018 Jun 06;9:1279
pubmed: 29951053
Clin Cancer Res. 2017 Oct 1;23(19):5789-5801
pubmed: 28634284
Nat Immunol. 2018 Feb;19(2):108-119
pubmed: 29348500
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
J Cancer Res Clin Oncol. 2020 Sep;146(9):2241-2253
pubmed: 32494918
Int Immunopharmacol. 2019 Oct;75:105818
pubmed: 31437795
Front Immunol. 2017 May 24;8:562
pubmed: 28596766
J Immunol. 2007 Jul 15;179(2):977-83
pubmed: 17617589
J Proteome Res. 2014 Feb 7;13(2):836-43
pubmed: 24295599
Arthritis Res Ther. 2018 Aug 3;20(1):168
pubmed: 30075733
Clin Immunol. 2016 Jan;162:118-24
pubmed: 26631755
J Cell Physiol. 2020 Feb;235(2):1723-1732
pubmed: 31301074
Circulation. 2018 Jul 10;138(2):181-197
pubmed: 29437117
Nat Rev Microbiol. 2018 Jul;16(7):397-409
pubmed: 29720707
Biochim Biophys Acta Mol Basis Dis. 2019 Dec 1;1865(12):165540
pubmed: 31470074
Bone. 2007 Feb;40(2):251-64
pubmed: 17098490
Nat Rev Immunol. 2019 Oct;19(10):626-642
pubmed: 31186549
J Leukoc Biol. 2015 Dec;98(6):913-22
pubmed: 26337512
Oncol Rep. 2021 Mar;45(3):1171-1181
pubmed: 33469683
Front Immunol. 2020 Jul 03;11:1299
pubmed: 32719675
Nature. 2000 Nov 30;408(6812):535-6
pubmed: 11117729
Clin Exp Pharmacol Physiol. 2017 Apr;44(4):455-462
pubmed: 28008635
Cancer Microenviron. 2015 Dec;8(3):125-58
pubmed: 24895166
PLoS One. 2017 Aug 16;12(8):e0183271
pubmed: 28813499
Blood. 2011 Feb 3;117(5):1540-9
pubmed: 21131587
Trends Mol Med. 2021 Jul;27(7):622-623
pubmed: 33811008
Cancer Res. 2007 Jan 1;67(1):425; author reply 426
pubmed: 17210725
Biomaterials. 2021 Jan;264:120405
pubmed: 33069135
Sci Rep. 2016 Aug 30;6:32259
pubmed: 27573075
Sci Rep. 2017 Oct 9;7(1):12808
pubmed: 28993671
Oncogene. 2017 Feb 2;36(5):639-651
pubmed: 27345402
PLoS One. 2012;7(11):e48871
pubmed: 23173040
Nat Commun. 2017 Apr 06;8:14979
pubmed: 28382931
Int J Mol Sci. 2020 Oct 14;21(20):
pubmed: 33066607